Cambridge Major Laboratories and AAIPharma Services have appointed Patrick Walsh as the Chief Executive of the merged company.
Walsh, formerly CEO of AAIPharma Services, has more than 30 years of leadership experience in the pharmaceutical industry.
The combined company, which came together earlier this month, has become a leading global supplier of integrated CMC services, including process chemistry, solid state chemistry, API manufacturing, formulation development, analytical development and testing services, clinical and commercial finished dosage form manufacturing (oral solid and sterile), packaging and stability services.
